ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Effect of lactoferrin on some selective immunological parameters in rats immunosuppressed by cyclophosphamide

Osama Ali Abdalla, Mohamed El-Sayed El-Boshy.



Abstract
Download PDF Post

Eighty male albino rats (350±10 g) 10 to 12 weeks old were conducted in our study. Rats were randomly divided into four, equal groups. The groups treated as following: 1st control group (Gp. A) was given intraperitoneal normal saline (1 mL). 2nd group (Gp. B) was given a single intraperitoneal dose (250 mg/kg body weight) of Cyclophosphamide (CP) on the first day of the experimental period. 3rd group (Gp. C) CP and lactoferrin (LF) treated group. 4th group (Gp. D) administrated LF only (0.5%) in drinking water. Two separate blood samples were collected from heart puncture at end of 1st and 3rd week post treatment for hematological, biochemical and immunological studies. The leukogram of CP treatment group showed severe leucopenia (lymphopenia, neutropenia as well as eozinopenia) as well as decrease total protein and albumin blood level. Immunosuppressive effect of CP is documented in our work by decrease gamma globulin and elevation tumor necrosis factor Alfa (TNF ά). This study revealed that oral treatment with LF can partially

Key words: Lactoferrin; immunomodulatory; cyclophosphamide.







Bibliomed Article Statistics

31
32
46
65
32
35
32
28
33
36
51
34
R
E
A
D
S

17

25

36

93

37

25

24

14

13

21

13

18
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.